Jude Canon

7.5k total citations
45 papers, 1.2k citations indexed

About

Jude Canon is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jude Canon has authored 45 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 30 papers in Oncology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jude Canon's work include Ubiquitin and proteasome pathways (8 papers), Cancer-related Molecular Pathways (8 papers) and Bone health and treatments (8 papers). Jude Canon is often cited by papers focused on Ubiquitin and proteasome pathways (8 papers), Cancer-related Molecular Pathways (8 papers) and Bone health and treatments (8 papers). Jude Canon collaborates with scholars based in United States, Poland and Australia. Jude Canon's co-authors include Utpal Banerjee, Paul Krogstad, Osvaldo Rey, Martine P. Roudier, William C. Dougall, R.J. Bryant, Angela Coxon, Paul J. Kostenuik, Marina Stolina and Sean Morony and has published in prestigious journals such as Genes & Development, SHILAP Revista de lepidopterología and Nature Neuroscience.

In The Last Decade

Jude Canon

44 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jude Canon United States 21 753 572 172 161 149 45 1.2k
Samuel Godár Austria 10 781 1.0× 491 0.9× 108 0.6× 330 2.0× 80 0.5× 11 1.5k
Leslie Petch United States 14 775 1.0× 198 0.3× 109 0.6× 134 0.8× 93 0.6× 16 1.3k
Chad M. McCall United States 20 964 1.3× 947 1.7× 54 0.3× 178 1.1× 45 0.3× 39 2.1k
Amy Donner United States 12 768 1.0× 230 0.4× 41 0.2× 154 1.0× 87 0.6× 30 1.1k
Kelly Barnes United States 7 1.1k 1.5× 270 0.5× 168 1.0× 283 1.8× 56 0.4× 9 1.7k
Kouji Matsushima Japan 9 543 0.7× 990 1.7× 107 0.6× 930 5.8× 54 0.4× 9 1.8k
Thierry Planchenault France 13 337 0.4× 328 0.6× 124 0.7× 344 2.1× 52 0.3× 22 956
Naoki Kakazu Japan 17 852 1.1× 265 0.5× 46 0.3× 335 2.1× 29 0.2× 40 1.5k
Evelyne Lauret France 19 610 0.8× 222 0.4× 81 0.5× 352 2.2× 34 0.2× 49 1.2k
Dalia Pinchasi Israel 8 648 0.9× 136 0.2× 59 0.3× 109 0.7× 88 0.6× 8 927

Countries citing papers authored by Jude Canon

Since Specialization
Citations

This map shows the geographic impact of Jude Canon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jude Canon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jude Canon more than expected).

Fields of papers citing papers by Jude Canon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jude Canon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jude Canon. The network helps show where Jude Canon may publish in the future.

Co-authorship network of co-authors of Jude Canon

This figure shows the co-authorship network connecting the top 25 collaborators of Jude Canon. A scholar is included among the top collaborators of Jude Canon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jude Canon. Jude Canon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Daniel, Tao Osgood, Shining Ma, et al.. (2024). KRAS inhibition triggers coordinated neoplastic and immune remodeling in the tumor microenvironment. The Journal of Immunology. 212(1_Supplement). 0875_7666–0875_7666.
2.
Terpos, Evangelos, Noopur Raje, Peter I. Croucher, et al.. (2021). Denosumab compared with zoledronic acid on PFS in multiple myeloma: exploratory results of an international phase 3 study. Blood Advances. 5(3). 725–736. 31 indexed citations
3.
Zafra, Christina L. Zuch de, Wendy Zhong, Matthew J. Bernett, et al.. (2019). Targeting Multiple Myeloma with AMG 424, a Novel Anti-CD38/CD3 Bispecific T-cell–recruiting Antibody Optimized for Cytotoxicity and Cytokine Release. Clinical Cancer Research. 25(13). 3921–3933. 99 indexed citations
4.
Saiki, Anne Y., Kevin Gaida, Karen Rex, et al.. (2019). Abstract 4484: Discovery and in vitro characterization of AMG 510–a potent and selective covalent small-molecule inhibitor of KRASG12C. 4484–4484. 1 indexed citations
5.
Swick, Adam D., Lauryn R. Werner, Kwangok P. Nickel, et al.. (2017). Radiosensitization of Adenoid Cystic Carcinoma with MDM2 Inhibition. Clinical Cancer Research. 23(20). 6044–6053. 21 indexed citations
6.
Werner, Lauryn R., Shyhmin Huang, David M. Francis, et al.. (2015). Small Molecule Inhibition of MDM2–p53 Interaction Augments Radiation Response in Human Tumors. Molecular Cancer Therapeutics. 14(9). 1994–2003. 40 indexed citations
7.
Canon, Jude, Tao Osgood, Steven H. Olson, et al.. (2015). The MDM2 Inhibitor AMG 232 Demonstrates Robust Antitumor Efficacy and Potentiates the Activity of p53-Inducing Cytotoxic Agents. Molecular Cancer Therapeutics. 14(3). 649–658. 116 indexed citations
8.
Coxon, Angela, James Bready, Stephen A. Kaufman, et al.. (2012). Anti-tumor activity of motesanib in a medullary thyroid cancer model.. PubMed. 35(2). 181–90. 22 indexed citations
9.
Canon, Jude, R.J. Bryant, Martine P. Roudier, Daniel Branstetter, & William C. Dougall. (2012). RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model. Breast Cancer Research and Treatment. 135(3). 771–780. 28 indexed citations
10.
Canon, Jude, R.J. Bryant, Martine P. Roudier, et al.. (2010). Inhibition of RANKL increases the anti-tumor effect of the EGFR inhibitor panitumumab in a murine model of bone metastasis. Bone. 46(6). 1613–1619. 30 indexed citations
11.
Canon, Jude, Martine P. Roudier, R.J. Bryant, et al.. (2007). Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis. Clinical & Experimental Metastasis. 25(2). 119–129. 154 indexed citations
12.
Sætrom, Pål, et al.. (2006). Conserved MicroRNA Characteristics in Mammals. Oligonucleotides. 16(2). 115–144. 46 indexed citations
13.
Yan, Huajun, Jude Canon, & Utpal Banerjee. (2003). A transcriptional chain linking eye specification to terminal determination of cone cells in the Drosophila eye. Developmental Biology. 263(2). 323–329. 60 indexed citations
14.
Canon, Jude & Utpal Banerjee. (2003). In vivo analysis of a developmental circuit for direct transcriptional activation and repression in the same cell by a Runx protein. Genes & Development. 17(7). 838–843. 39 indexed citations
15.
Krogstad, Paul, Yongzhi Geng, Osvaldo Rey, et al.. (2002). Human Immunodeficiency Virus Nucleocapsid Protein Polymorphisms Modulate the Infectivity of RNA Packaging Mutants. Virology. 294(2). 282–288. 7 indexed citations
16.
Nagaraj, Raghavendra, Jude Canon, & Utpal Banerjee. (2002). Cell Fate Specification in the Drosophila Eye. Results and problems in cell differentiation. 37. 73–88. 14 indexed citations
17.
Kaminker, Joshua S., Jude Canon, Iris Salecker, & Utpal Banerjee. (2002). Control of photoreceptor axon target choice by transcriptional repression of Runt. Nature Neuroscience. 5(8). 746–750. 52 indexed citations
18.
Ibarrondo, F. Javier, Ruth Choi, Yongzhi Geng, et al.. (2001). HIV Type 1 Gag and Nucleocapsid Proteins: Cytoskeletal Localization and Effects on Cell Motility. AIDS Research and Human Retroviruses. 17(16). 1489–1500. 28 indexed citations
19.
Rey, Osvaldo, Jude Canon, & Paul Krogstad. (1996). HIV-1 Gag Protein Associates with F-actin Present in Microfilaments. Virology. 220(2). 530–534. 99 indexed citations
20.
Krogstad, Paul, Irvin S. Y. Chen, Jude Canon, & Osvaldo Rey. (1996). Quantitative Analysis of the Endogenous Reverse Transcriptase Reactions of HIV Type 1 Variants with Decreased Susceptibility to Azidothymidine and Nevirapine. AIDS Research and Human Retroviruses. 12(11). 977–983. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samuel Godár Breakdown of academic impact, for papers by Leslie Petch Breakdown of academic impact, for papers by Chad M. McCall Breakdown of academic impact, for papers by Amy Donner Breakdown of academic impact, for papers by Kelly Barnes Breakdown of academic impact, for papers by Kouji Matsushima Breakdown of academic impact, for papers by Thierry Planchenault Breakdown of academic impact, for papers by Naoki Kakazu Breakdown of academic impact, for papers by Evelyne Lauret Breakdown of academic impact, for papers by Dalia Pinchasi
Rankless by CCL
2026